查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1946396

植物幹細胞市場－全球產業規模、佔有率、趨勢、機會及預測（按地區、應用、區域和競爭格局分類，2021-2031年）

Plant Stem Cell Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Location, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球植物幹細胞市場預計將從 2025 年的 4.1412 億美元成長到 2031 年的 6.8351 億美元，複合年成長率為 8.71%。

這些幹細胞是從植物分生組織中提取的未分化細胞，在受控的實驗室環境中培養，用於生產製藥和化妝品行業所需的特定生物活性化合物。該領域的成長主要源自於對兼具卓越純度和效力，同時又能保護自然生物多樣性的永續成分日益成長的需求。此外，製造商正積極採用這項技術，以確保原料的穩定性和供應鏈的穩定，而這些因素使得傳統的田間種植作物更容易受到氣候變遷的影響。

市場概覽
預測期 2027-2031
市場規模：2025年 4.1412億美元
市場規模：2031年 6.8351億美元
複合年成長率：2026-2031年 8.71%
成長最快的細分市場 化妝品
最大的市場 北美洲

生物技術的應用正受到日益壯大的認證天然成分網路的推動。 NATRUE 2024年的數據顯示，全球約有10,000種產品和成分帶有NATRUE標籤，這表明標準化天然成分的商業性框架已相當穩固。然而，生技基礎設施所需的高額資本投入仍是市場擴張的一大障礙。建造和擴大生物反應器系統的成本巨大，可能會限制盈利，因此，這項技術的應用往往主要局限於高級產品領域。

市場促進因素

全球對活膚和抗衰老產品的需求日益成長，是推動植物幹細胞技術應用的主要動力。消費者傾向於選擇能帶來實際效果（例如增加肌膚密度和減少皺紋）的高效配方，因此各大品牌紛紛轉向以強大抗氧化特性著稱的分生組織細胞培養技術。這種對功效的商業性需求也反映在小眾成分開發商的財務表現上。例如，Vytrus Biotech在2024年4月發布的2024年第一季財報中顯示，其全球銷售額成長了32%，並將這一成長主要歸功於歐美護膚市場的復甦。

同時，對環保和永續採購的重視正在改變工業實踐，生物技術為傳統收割方式提供了一種資源高效的替代方案。利用生物反應器，製造商可以在不耗盡稀有植物物種或佔用大片耕地的情況下生產穩定的生物活性成分，從而幫助大型企業實現其嚴格的環境目標。歐萊雅等業界領導者便是這股趨勢的典範。歐萊雅在其2024年3月發布的2023年度報告中重點強調了其向可再生原料的轉型，並指出其65%的成分為生物基成分。此外，根據英國美容協會於2024年8月發布的《2024年美容價值報告》，預計2023年個人護理業將為英國GDP貢獻272億英鎊，為先進的化妝品解決方案提供強勁的經濟基礎。

市場挑戰

全球植物幹細胞市場成長的主要障礙在於生物技術基礎設施所需的大量資本投入。生物反應器系統的開發和規模化建設需要大量的前期投資和持續的營運成本，這直接推高了最終原料的價格。這種經濟模式迫使植物幹細胞化合物維持在高價位，從而有效地阻礙了它們在大眾市場化妝品中的應用，而成本效益和微薄的利潤率在這些領域至關重要。

因此，市場規模成長受到限制，因為中小企業往往缺乏足夠的財力來採用這項技術或購買如此高價值的原料。該行業的資源密集型特性也造成了很高的進入門檻。根據2024年歐洲化妝品協會的數據，歐洲化妝品產業在研發方面的投資約為23億歐元，這凸顯了支持此類先進創新所需的資本密集環境。這種高額的資本需求限制了市場參與者的數量，使這項技術只能作為小眾產品，並阻礙了其在更廣泛的產品類型中的商業性應用。

市場趨勢

頭皮護理和毛囊再生領域的拓展標誌著市場關注點顯著超越了臉部美容。供應商正在調整最初用於改善皮膚密度的植物細胞培養技術，以靶向毛囊訊號通路和維持生長期的微生物群。這一被稱為「護髮護膚品的皮膚化」的趨勢，正促使品牌將高價值的生物技術活性成分融入精華液和洗髮精中，以滿足消費者對治療頭髮稀疏和脫髮症的臨床級效果的需求。歐洲化妝品協會於2025年6月發布的《2024年市場表現報告》強調了該領域的商業性潛力，報告顯示，歐洲護髮市場成長5.6%，零售額達到181億歐元，凸顯了功能性成分整合的盈利潛力。

同時，人工智慧在活性成分分析和發現領域的應用，正在改變製造商檢測和提煉植物幹細胞中強效植物化學物質的方式。機器學習模型和預測演算法取代了傳統的試驗誤法，用於繪製細胞培養代謝組圖譜，使研究人員能夠在規模化生產之前識別出具有特定保護或表觀遺傳功能的稀有化合物。這種數位化提高了功效聲明的準確性，並顯著縮短了新型生物活性成分的研發前置作業時間。主要企業的支出趨勢也反映了這個策略轉變。歐萊雅於2025年3月發布的2024年度報告顯示，公司在研發和創新方面的投資超過13億歐元，強調了人工智慧與綠色科學的融合將加速先進美容解決方案的發展。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球植物幹細胞市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依位置（莖尖分生組織、根尖分生組織、維管分生組織）
    • 依用途（營養、藥品、化妝品）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美植物幹細胞市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲植物幹細胞市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區植物幹細胞市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲植物幹細胞市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲植物幹細胞市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球植物幹細胞市場：SWOT分析

第14章 波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Uniliver PLC
  • Renature Skin Care Inc.
  • PhytoScience Ltd.
  • Oriflame Cosmetics AG
  • MyChelle Dermaceuticals LLC
  • Mibelle Group AG
  • Juice Beauty LLC
  • Emsland Group GmbH
  • Bio-FD&C Co., Ltd.
  • Aidan Products LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 17262

The Global Plant Stem Cell Market is projected to expand from USD 414.12 Million in 2025 to USD 683.51 Million by 2031, reflecting a CAGR of 8.71%. These stem cells, which are undifferentiated cells obtained from plant meristematic tissue, are cultivated in controlled laboratory settings to produce specific bioactive compounds for the pharmaceutical and cosmetic industries. Growth in this sector is largely propelled by the rising demand for sustainable ingredients that provide exceptional purity and potency while protecting natural biodiversity. Additionally, manufacturers are increasingly embracing this technology to guarantee ingredient consistency and supply chain stability, factors often compromised by climatic fluctuations in traditional field-grown crops.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 414.12 Million
Market Size 2031USD 683.51 Million
CAGR 2026-20318.71%
Fastest Growing SegmentCosmetics
Largest MarketNorth America

This transition toward biotechnology is bolstered by an expanding network of certified natural inputs, evidenced by NATRUE's 2024 data showing nearly 10,000 products and raw materials bearing the NATRUE Label globally, signaling a robust commercial framework for standardized natural ingredients. However, the high capital expenditure necessary for biotechnological infrastructure remains a substantial obstacle to wider market growth. The significant costs associated with establishing and scaling bioreactor systems can constrain profitability, thereby limiting the adoption of this technology primarily to premium product tiers.

Market Driver

The increasing global demand for skin rejuvenation and anti-aging products serves as a major driver for the integration of plant stem cell technology. As consumers prioritize high-performance formulations that offer tangible improvements in skin density and wrinkle reduction, brands are turning to meristematic cell cultures recognized for their potent antioxidant capabilities. This commercial demand for efficacy is reflected in the financial performance of niche ingredient developers; for instance, Vytrus Biotech reported a 32% global sales increase in its Q1 2024 results released in April 2024, a surge attributed largely to the rebounding skincare markets in Europe and the United States.

Concurrently, the focus on eco-friendly and sustainable ingredient sourcing is transforming industrial methods, with biotechnology providing a resource-efficient substitute for traditional harvesting. By utilizing bioreactors, manufacturers can generate consistent bioactive ingredients without exhausting rare plant species or occupying extensive arable land, meeting the strict environmental goals of large conglomerates. This trend is illustrated by industry leaders like L'Oreal, which noted in its March 2024 '2023 Annual Report' that 65% of its raw materials were bio-based, highlighting the shift to renewable inputs. Furthermore, the British Beauty Council's 'Value of Beauty Report 2024', published in August 2024, revealed that the personal care sector added £27.2 billion to the UK GDP in 2023, indicating a strong economic backdrop for advanced cosmetic solutions.

Market Challenge

A major hurdle to the growth of the Global Plant Stem Cell Market is the significant capital expenditure needed for biotechnological infrastructure. The development and scaling of bioreactor systems entail substantial upfront investment and continuous operational costs, which directly increase the final price of the produced ingredients. This economic framework forces plant stem cell compounds to remain within the premium price bracket, effectively blocking their inclusion in mass-market cosmetic products where cost efficiency and tight profit margins are critical.

As a result, the market experiences limited volume growth because small and medium-sized enterprises frequently lack the financial capacity to implement this technology or acquire such high-value inputs. The resource-intensive nature of this industry establishes a high entry barrier; according to Cosmetics Europe data from 2024, the European industry poured roughly 2.3 billion euros into research and development, highlighting the capital-heavy environment needed to support such advanced innovation. This elevated financial requirement restricts the number of market players and keeps the technology as a niche offering, impeding its widespread commercial application across broader product categories.

Market Trends

The expansion into scalp care and hair follicle regeneration marks a significant broadening of the market's focus beyond facial aesthetics. Suppliers are increasingly adapting plant cell cultures, initially designed for skin density, to target the signaling pathways and microbiota of hair follicles responsible for maintaining the anagen phase. This trend, often referred to as the "skinification" of hair care, meets consumer demand for clinical-level efficacy in addressing thinning hair and alopecia, encouraging brands to add high-value biotech actives to serums and shampoos. The sector's commercial potential is highlighted by Cosmetics Europe's 'Market Performance 2024' report from June 2025, which notes that the European hair care category expanded by 5.6% to a retail value of 18.1 billion euros, offering a profitable path for functional ingredient integration.

Simultaneously, the incorporation of AI into the profiling and discovery of active ingredients is transforming how manufacturers detect and refine potent phytochemicals in plant stem cells. Replacing traditional trial-and-error methods, machine learning models and predictive algorithms are now employed to map cell culture metabolomes, enabling researchers to identify rare compounds with specific protective or epigenetic functions prior to physical scaling. This digitization improves the accuracy of efficacy claims and drastically shortens the lead time for introducing new bio-actives. Major corporate spending reflects this strategic pivot; L'Oreal's '2024 Annual Report' from March 2025 indicates an investment of over 1.3 billion euros in Research & Innovation, emphasizing the fusion of artificial intelligence and green sciences to expedite the development of advanced beauty solutions.

Key Market Players

  • Uniliver PLC
  • Renature Skin Care Inc.
  • PhytoScience Ltd.
  • Oriflame Cosmetics AG
  • MyChelle Dermaceuticals LLC
  • Mibelle Group AG
  • Juice Beauty LLC
  • Emsland Group GmbH
  • Bio-FD&C Co., Ltd.
  • Aidan Products LLC

Report Scope

In this report, the Global Plant Stem Cell Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Plant Stem Cell Market, By Location

  • Shoot Apical Meristems
  • Root Apical Meristems
  • Vascular Meristems

Plant Stem Cell Market, By Application

  • Nutrition
  • Pharmaceutical
  • and Cosmetics

Plant Stem Cell Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Plant Stem Cell Market.

Available Customizations:

Global Plant Stem Cell Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Plant Stem Cell Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Location (Shoot Apical Meristems, Root Apical Meristems, Vascular Meristems)
    • 5.2.2. By Application (Nutrition, Pharmaceutical, and Cosmetics)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Plant Stem Cell Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Location
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Plant Stem Cell Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Location
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Plant Stem Cell Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Location
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Plant Stem Cell Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Location
        • 6.3.3.2.2. By Application

7. Europe Plant Stem Cell Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Location
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Plant Stem Cell Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Location
        • 7.3.1.2.2. By Application
    • 7.3.2. France Plant Stem Cell Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Location
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Plant Stem Cell Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Location
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Plant Stem Cell Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Location
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Plant Stem Cell Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Location
        • 7.3.5.2.2. By Application

8. Asia Pacific Plant Stem Cell Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Location
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Plant Stem Cell Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Location
        • 8.3.1.2.2. By Application
    • 8.3.2. India Plant Stem Cell Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Location
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Plant Stem Cell Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Location
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Plant Stem Cell Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Location
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Plant Stem Cell Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Location
        • 8.3.5.2.2. By Application

9. Middle East & Africa Plant Stem Cell Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Location
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Plant Stem Cell Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Location
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Plant Stem Cell Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Location
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Plant Stem Cell Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Location
        • 9.3.3.2.2. By Application

10. South America Plant Stem Cell Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Location
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Plant Stem Cell Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Location
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Plant Stem Cell Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Location
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Plant Stem Cell Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Location
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Plant Stem Cell Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Uniliver PLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Renature Skin Care Inc.
  • 15.3. PhytoScience Ltd.
  • 15.4. Oriflame Cosmetics AG
  • 15.5. MyChelle Dermaceuticals LLC
  • 15.6. Mibelle Group AG
  • 15.7. Juice Beauty LLC
  • 15.8. Emsland Group GmbH
  • 15.9. Bio-FD&C Co., Ltd.
  • 15.10. Aidan Products LLC

16. Strategic Recommendations

17. About Us & Disclaimer